Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study

Clinical trial NCT00604383 · COMPLETED

Trial details

NCT number: NCT00604383
Sponsor: Chromaderm, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2001-03-01
Primary completion: 2005-06-01
Enrollment: 685

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.